Real-world utilization of cabotegravir plus rilpivirine in Southern Spain: data from the CARIPLA study

被引：0
|
作者：
Palacios, Rosario [1 ]
Gomez-Ayerbe, Cristina [1 ]
Mayorga, Marisa [2 ]
Espinosa, Nuria [3 ]
Hidalgo, Alicia [4 ]
Tellez, Francisco [5 ]
Lozano, Ana Belen [6 ]
Loring, Monica
Santos, Jesus [1 ,7 ]
机构：
[1] Hosp Univ Virgen Victoria, Infect Dis Unit, Malaga, Spain
[2] Hosp Reg Carlos Haya, Infect Dis Unit, Malaga, Spain
[3] Hosp Virgen Rocio, Infect Dis Unit, Seville, Spain
[4] Hosp Juan Ramon Jimenez, Infect Dis Unit, Huelva, Spain
[5] Hosp Puerto Real, Infect Dis, Cadiz, Spain
[6] Hosp El Ejido, Infect Dis Unit, Almeria, Spain
[7] Hosp Axarquia, Internal Med, Malaga, Spain
来源：
JOURNAL OF THE INTERNATIONAL AIDS SOCIETY | 2024年 / 27卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
P084
引用
收藏
页码：94 / 94
页数：1
相关论文
共 50 条
  • [31] Migraine treatment: quo vadis? Real-world data study (2015–2022) in Spain
    Patricia Pozo-Rosich
    Mafalda Carmo
    Alejandro Muñiz
    Beatriz Armada
    Carlota Moya-Alarcón
    Julio Pascual
    BMC Neurology, 24
  • [32] Cenobamate: real-world data from a retrospective multicenter study
    Lauxmann, Stephan
    Heuer, David
    Heckelmann, Jan
    Fischer, Florian P.
    Schreiber, Melanie
    Schriewer, Elisabeth
    Widman, Guido
    Weber, Yvonne
    Lerche, Holger
    Alber, Michael
    Schuh-Hofer, Sigrid
    Wolking, Stefan
    JOURNAL OF NEUROLOGY, 2024, : 6596 - 6604
  • [33] LTreatment sequencing in NSCLC EGFR plus - real-world data
    Fernandes, Ana Luisa
    Dias, Margarida
    Coutinho, Daniel
    Silva, Eloisa
    Costa, Telma
    Campainha, Sergio
    Conde, Sara
    Barroso, Ana
    EUROPEAN RESPIRATORY JOURNAL, 2020, 56
  • [34] Drug utilization research in Peru: Is real-world data available?
    Yesenia Rodriguez-Tanta, L.
    Garavito Farro, Hector
    Freitas Leal, Lisiane
    Salas, Maribel
    Elseviers, Monique M.
    Cruz Lopes, Luciane
    FRONTIERS IN PHARMACOLOGY, 2023, 13
  • [35] Safety and effectiveness of ocrelizumab in multiple sclerosis: a real-world study from spain
    Sempere, A.
    Berenguer-Ruiz, L.
    Burgos-San Jose, A.
    Aragones, M.
    Navarro-Lopez, M. D.
    MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (3_SUPPL) : 553 - 553
  • [36] Clinical and pharmacological outcomes of real-world use of Long-Acting Cabotegravir and Rilpivirine in France: Efficacy and tolerance during the first 72 weeks
    Psomas, C. K.
    Halfon, P.
    Salnikova, M.
    Khiri, H.
    Tichadelle, F.
    Allemand, J.
    Neant, N.
    Solas, C.
    Philibert, P.
    HIV MEDICINE, 2023, 24 : 81 - 82
  • [37] Efficacy of TIPS plus extrahepatic collateral embolisation in real-world data: a validation study
    Zhao, Lianhui
    Tie, Jun
    Wang, Guangchuan
    Li, Zhengjie
    Xu, Jiao
    Zhuge, Yuzheng
    Zhang, Feng
    Wu, Hao
    Wei, Bo
    Xue, Hui
    Li, Peijie
    Wu, Wei
    Chen, Chao
    Wu, Qiong
    Xia, Yifu
    Sun, Xiubin
    Zhang, Chunqing
    BMJ OPEN GASTROENTEROLOGY, 2024, 11 (01):
  • [38] Virological failure rate and emergent resistance in real-world studies evaluating long-acting cabotegravir and rilpivirine in people with baseline viral suppression
    Smuk, Melanie
    Elias, Alexa
    Ring, Kyle
    Orkin, Chloe
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2024, 27 : 97 - 98
  • [39] Developing real-world evidence from real-world data: Transforming raw data into analytical datasets
    Bastarache, Lisa
    Brown, Jeffrey S.
    Cimino, James J.
    Dorr, David A.
    Embi, Peter J.
    Payne, Philip R. O.
    Wilcox, Adam B.
    Weiner, Mark G.
    LEARNING HEALTH SYSTEMS, 2022, 6 (01):
  • [40] Perspectives on the acceptability, appropriateness, feasibility, barriers, and facilitators from patients receiving cabotegravir plus rilpivirine long-acting injectable treatment (CAB plus RPV LA): interim results from the Cabotegravir and Rilpivirine Implementation Study in European Locations (CARISEL)
    Hocqueloux, L.
    Gutner, C.
    DeMoor, R.
    Gill, M.
    Trehan, R.
    D'Amico, R.
    Tomkins, S.
    Schroeder, M.
    Bontempo, G.
    Ait-Khaled, M.
    Hadi, M.
    Anand, S. Bakhshi
    Low, E. L.
    Jeanmaire, E.
    Crusells Canales, M.
    Vandekerckhove, L.
    Bonnet, F.
    Olalla Sierra, J.
    Czarnogorski, M.
    HIV MEDICINE, 2021, 22 : 99 - 99
12345